These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18365787)

  • 21. Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients.
    Kissling W; Glue P; Medori R; Simpson S
    Hum Psychopharmacol; 2007 Dec; 22(8):505-13. PubMed ID: 17902187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
    J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
    Golubchik P; Sever J; Zalsman G; Weizman A
    Int Clin Psychopharmacol; 2008 Jul; 23(4):228-31. PubMed ID: 18446088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of borderline personality disorder with risperidone.
    Rocca P; Marchiaro L; Cocuzza E; Bogetto F
    J Clin Psychiatry; 2002 Mar; 63(3):241-4. PubMed ID: 11926724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
    Keith S
    Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quetiapine for the treatment of borderline personality disorder; an open-label study.
    Perrella C; Carrus D; Costa E; Schifano F
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):158-63. PubMed ID: 17045720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antipsychotics in treatment of eating disorders patient: a study with risperidone].
    Beato Fernández L; Rodríguez Cano T
    Actas Esp Psiquiatr; 2005; 33(1):33-40. PubMed ID: 15704029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V
    Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.
    Friedel RO; Jackson WT; Huston CS; May RS; Kirby NL; Stoves A
    J Clin Psychopharmacol; 2008 Jun; 28(3):345-7. PubMed ID: 18480695
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of long-acting risperidone in the treatment of bipolar patients.
    Savas HA; Yumru M; Ozen ME
    J Clin Psychopharmacol; 2006 Oct; 26(5):530-1. PubMed ID: 16974200
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term administration of the low-dose risperidone in schizotaxia subjects.
    Rybakowski JK; Drozdz W; Borkowska A
    Hum Psychopharmacol; 2007 Aug; 22(6):407-12. PubMed ID: 17597479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
    Perez V; Cañas F; Tafalla M;
    Int Clin Psychopharmacol; 2008 May; 23(3):138-49. PubMed ID: 18408528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quetiapine in patients with borderline personality disorder: an open-label trial.
    Adityanjee ; Romine A; Brown E; Thuras P; Lee S; Schulz SC
    Ann Clin Psychiatry; 2008; 20(4):219-26. PubMed ID: 19034754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.
    Van den Eynde F; Senturk V; Naudts K; Vogels C; Bernagie K; Thas O; van Heeringen C; Audenaert K
    J Clin Psychopharmacol; 2008 Apr; 28(2):147-55. PubMed ID: 18344724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of long-acting paliperidone palmitate in borderline personality disorder.
    Palomares N; Montes A; Díaz-Marsá M; Carrasco JL
    Int Clin Psychopharmacol; 2015 Nov; 30(6):338-41. PubMed ID: 26230268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
    Nosè M; Cipriani A; Biancosino B; Grassi L; Barbui C
    Int Clin Psychopharmacol; 2006 Nov; 21(6):345-53. PubMed ID: 17012981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do formulation switches exacerbate existing medical illness? Results of an open-label transition to orally disintegrating risperidone tablets.
    Chue P; Prinzo RS; Binder CE
    Hum Psychopharmacol; 2007 Jul; 22(5):307-14. PubMed ID: 17487933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.